NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 242 filers reported holding NEKTAR THERAPEUTICS in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49 | +2.1% | 83 | 0.0% | 0.00% | – |
| Q2 2023 | $48 | -17.2% | 83 | 0.0% | 0.00% | – |
| Q1 2023 | $58 | -69.1% | 83 | 0.0% | 0.00% | – |
| Q4 2022 | $188 | – | 83 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 83 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 83 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 83 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 83 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 83 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 83 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 83 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 83 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 83 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 83 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 83 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 83 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | -33.3% | 83 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 83 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | 0.0% | 83 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -40.0% | 83 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | +25.0% | 83 | 0.0% | 0.00% | – |
| Q2 2018 | $4,000 | – | 83 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 1,350,000 | $22,950,000 | 1.87% |
| MAVERICK CAPITAL LTD | 6,655,625 | $113,146,000 | 1.81% |
| Camber Capital Management LP | 2,500,000 | $42,500,000 | 1.49% |
| Bellevue Group AG | 3,866,258 | $65,726,000 | 0.75% |
| Adero Partners, LLC | 51,500 | $876,000 | 0.75% |
| Goodman Financial Corp | 108,342 | $1,842,000 | 0.64% |
| CM Management, LLC | 35,000 | $595,000 | 0.55% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 424,504 | $7,217,000 | 0.43% |
| RICE HALL JAMES & ASSOCIATES, LLC | 568,379 | $9,662,000 | 0.34% |
| Burleson & Company, LLC | 107,736 | $1,832,000 | 0.32% |